Drug Type Aptamer drug conjugates |
Synonyms |
Target |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
GPC3 Positive Hepatocellular Carcinoma | IND Application | KR | 12 Mar 2024 | |
GPC3 Positive Neoplasms | IND Application | KR | 12 Mar 2024 | |
Solid tumor | Preclinical | KR | - |